Michelle Renee Griffin, Director at Adaptive Biotechnologies Corp (ADPT), sold 2,341 shares at $8.49 ($20K) on 2023-03-27, disclosed to the SEC on 2023-03-29.
Scheduled sale ($20k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ADPT | SELL | 2026-03-05 | $735K | — | Filing → |
| ADPT | SELL | 2025-03-17 | $522K | — | Filing → |
| ADPT | SELL | 2025-03-06 | $249K | — | Filing → |